Zurich Cantonal Bank
PLRX icon

Zurich Cantonal Bank’s Pliant Therapeutics PLRX Stock Holding History

Zurich Cantonal Bank’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36
Closed -$44 – 3268
2025
Q4 		$44 Buy
+36
New +$54 ﹤0.01% 2526

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Zurich Cantonal Bank's PLRX Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Pliant Therapeutics (PLRX) in Q1 2026: 36 shares worth $45. The stake represents ﹤0.01% of the portfolio and ranks #2528 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in PLRX as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in PLRX in Q4 2022 and has held it in 13 quarters since. The position peaked at $166K in Q1 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Zurich Cantonal Bank held 36 shares of Pliant Therapeutics worth $45 as of Q1 2026.
  • Pliant Therapeutics was a new Zurich Cantonal Bank position in Q1 2026.
  • Pliant Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2528 holding.
  • Zurich Cantonal Bank first reported a position in Pliant Therapeutics in Q4 2022 and has held it in 13 quarters since.
  • Zurich Cantonal Bank's Pliant Therapeutics position peaked at $166K in Q1 2023.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.